Showing 471-480 of 3844 results for "".
DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyLearning to Improve Patient Care
https://practicaldermatology.com/series/dermatology-education-foundation/learning-to-improve-patient-care/19991/Wendy Cantrell, CRNP, DNP says one take-home pearl she's especially happy to be taking home came from Hilary Baldwin's session on keloids. She now has a new treatment algorithm plus tips for talking to patients about this difficult to treat condition.Scientifically Speaking: New Directions in Acne Management, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-1/19939/The recognition that inflammation is at the heart of acne has led to changes in management approaches and better understanding of how treatments work. In the first of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD about acne approachesUncommon Knowledge: Horses v. Zebras in Pediatric Dermatology
https://practicaldermatology.com/conferences/aad-2021/uncommon-knowledge-horses-v-zebras-in-pediatric-dermatology/19924/Even though uncommon presentations of common conditions are more likely than common presentations of uncommon conditions, uncommon conditions do present, says Colleen Cotton, MD. She addresses the importance of finding the proper diagnosis in pediatric skin disease, noting cases of venous malformatiIn the Pipeline: What to Know About Tapinarof
https://practicaldermatology.com/topics/psoriasis/in-the-pipeline-what-to-know-about-tapinarof/23320/Here’s a closer look at the novel topical being studied for psoriasis and atopic dermatitis.DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-19-loans-taltz-for-peds-finacea-returns/19808/SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients aSkin Care for All
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-care-for-all/19708/Every patient gets skin care, says Michael Gold, MD, who says that a number of good products are now on the market. He identifies some leading formulations.Family Affair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/family-affair/19697/Fun, fresh, and scientific. That's how host Joel Cohen, MD describes CSF—now in its 11th year. Meeting founder Joel Schlessinger, MD weighs in on his vision for the meeting and what he learned this year.Innovations in Hair Restoration
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/innovations-in-hair-restoration-/19564/Neil Sadick, MD, provides an overview of innovations in hair restoration. According to Dr. Sadick, a number of novel and investigational techniques and devices, coupled with emerging science on the environmental influences on hair loss, make 2019 an exciting time for correcting hair loss.In-depth Content
https://practicaldermatology.com/topics/practice-management/in-depth-content/18306/Crisp, concise content is the need of the hour when it comes to your dermatology website. This Ekwa Marketing video outlines how you can achieve this with the help of short, bite-sized answers to long-tail questions that can then be shared on your site and social media.